Patients with severe obesity who completed a milk-based LELD had significant short-term increases in adiponectin and reductions in leptin and the LAR, consistent with decreased insulin resistance, which was proportional to the amount of weight lost. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.